{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:59:33Z","timestamp":1792159173588,"version":"4.4.0"},"reference-count":45,"publisher":"Massachusetts Medical Society","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.1056\/nejmoa2510308","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:00:23Z","timestamp":1760709623000},"page":"27-38","source":"Crossref","is-referenced-by-count":122,"title":["Survival with Osimertinib plus Chemotherapy in\n                    <i>EGFR<\/i>\n                    -Mutated Advanced NSCLC"],"prefix":"10.1056","volume":"394","author":[{"given":"Pasi A.","family":"J\u00e4nne","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana\u2013Farber Cancer Institute, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Gustave Roussy, Thoracic Unit, Villejuif, France"},{"name":"Faculty of Medicine, Universit\u00e9 Paris-Saclay, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Chih-Hsin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Graduate Institute of Oncology, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Valdiviezo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-4426","authenticated-orcid":false,"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kagamu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yanagitani","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6101-5500","authenticated-orcid":false,"given":"Bivas","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Medical Center, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Poltoratskiy","sequence":"additional","affiliation":[{"name":"Petrov Research Institute of Oncology, St. Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeni","family":"Neron","sequence":"additional","affiliation":[{"name":"Oncology Research Center, Florianopolis, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rojas","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Koubkova","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Motol University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-3202","authenticated-orcid":false,"given":"Carles","family":"Escriu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Clatterbridge Cancer Centre National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen A.","family":"Ezeife","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mann","sequence":"additional","affiliation":[{"name":"Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Armenteros-Monterroso","sequence":"additional","affiliation":[{"name":"Oncology Research and Development, AstraZeneca, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Rukazenkov","sequence":"additional","affiliation":[{"name":"Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Khoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Care Centre, St. George Hospital, Kogarah, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0337"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612674"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027071"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.9363"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.3118"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913662"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02785"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.009"},{"key":"e_1_3_5_11_2","unstructured":"Hendriks LE Cortiula F Mariamidze E Martins-Branco D Pentheroudakis G Reck M. ESMO living guideline: oncogene-addicted non-small cell lung cancer version 1.2. European Society for Medical Oncology January 2025 (https:\/\/www.esmo.org\/guidelines\/living-guidelines\/esmo-living-guideline-oncogene-addicted-metastatic-non-small-cell-lung-cancer)."},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02911"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01488"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01154"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30806"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100271"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102589"},{"key":"e_1_3_5_19_2","unstructured":"Tagrisso. Wilmington DE: AstraZeneca 2024 (package insert) (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/208065s031lbl.pdf)."},{"key":"e_1_3_5_20_2","unstructured":"Tagrisso. S\u00f6dert\u00e4lje Sweden: AstraZeneca 2022 (package insert) (https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tagrisso-epar-product-information_en.pdf)."},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103996"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/M22-1460"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102588"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3759"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.013"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4451"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0175"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279512"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx758"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101139"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1380358"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2012.0064"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403614"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503001"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7578"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.11.032"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.05.008"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00166-1"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji055"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22208"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31827628ff"},{"key":"e_1_3_5_42_2","unstructured":"Food and Drug Administration. FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer. June 23 2025 (https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-datopotamab-deruxtecan-dlnk-egfr-mutated-non-small-cell-lung-cancer)."},{"key":"e_1_3_5_43_2","unstructured":"Food and Drug Administration. FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression. May 14 2025 (https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-telisotuzumab-vedotin-tllv-nsclc-high-c-met-protein-overexpression)."},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-085680"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100630"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.184"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2510308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:28:58Z","timestamp":1781742538000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2510308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1056\/NEJMoa2510308"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2510308","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}